ImmuPharma (GB:IMM) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
ImmuPharma PLC has announced a significant change in share ownership, with Lanstead Capital Investors LP’s voting rights crossing a threshold on August 2, 2024, resulting in their total voting rights in the company dropping from 12.99% to 9.99%. This financial movement was formally notified to the company and the relevant authorities on August 6, 2024.
For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue